CDKN1A and acute myeloid leukemia: We then evaluated both protein and transcriptional expression levels of CDKN1A/p21 in OCI-AML 3 SCR and shNS and we observed modestly increased levels of CDKN1A/p21 under NS silencing, thus confirming IPA predictions (Figure 2B).